Regeneron Pharmaceuticals (REGN)
Add to Watchlists Create an Alert
256.93
-5.49 -2.09%
NASDAQ
May 23, 12:47PM
BATS Real time
Currency in USD
Regeneron Pharmaceuticals Free Cash Flow:
65.04M for March 31, 2013Regeneron Pharmaceuticals Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 65.04M |
| Dec. 31, 2012 | 78.02M |
| Sept. 30, 2012 | -12.63M |
| June 30, 2012 | -91.25M |
| March 31, 2012 | -98.10M |
| Dec. 31, 2011 | -61.61M |
| Sept. 30, 2011 | -55.63M |
| June 30, 2011 | -48.91M |
| March 31, 2011 | -32.75M |
| Dec. 31, 2010 | -73.11M |
| Sept. 30, 2010 | 139.40M |
| June 30, 2010 | -34.43M |
| March 31, 2010 | -32.32M |
| Dec. 31, 2009 | -68.72M |
| Sept. 30, 2009 | -32.15M |
| June 30, 2009 | -31.38M |
| March 31, 2009 | -37.30M |
| Dec. 31, 2008 | -51.58M |
| Sept. 30, 2008 | -50.87M |
| June 30, 2008 | -0.545M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
REGN Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Sanofi | |
| Celgene Corporation | 341.20M |
| Exelixis | -39.92M |
REGN Free Cash Flow Rankings
| Overall |
91st percentile 651 of 8006 |
| Sector |
90th percentile 64 of 686 in Healthcare |
| Industry |
96th percentile 9 of 248 in Biotechnology |
REGN Free Cash Flow Range, Past 5 Years
| Minimum | -98.10M | Mar 2012 |
| Maximum | 139.40M | Sep 2010 |
| Average | -26.54M |
